http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103656057-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e60f8721e20388a22c4ad467cbaf264 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate | 2012-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c598add229daf36c6fbcc1a66ace6adb |
publicationDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103656057-A |
titleOfInvention | Compound medicine for treating rheumatoid arthritis |
abstract | The invention relates to a compound medicine for treating rheumatoid arthritis and a preparation method thereof. The invention is characterized in that the medicine is prepared from selected Chinese medicinal herb essence components with reasonable compatibility by a special technique. The medicine is prepared from pure Chinese medicinal herb components and is free of any chemical component. The Chinese medicinal herb components are strictly screened and proportioned through the experiments, so the medicine has favorable compound effect. The medicine is prepared by a special technique, has the advantages of stable quality and no toxic or side effect on the human body, is convenient to take, and is used for treating rheumatoid arthritis which has the main clinical features of chronic, symmetrical and polysynovitis arthritis and extra-articular pathological changes, i.e. arthritis caused by deficiency in meridian qi and blood and malnutrition of bones and muscles. |
priorityDate | 2012-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.